Latest Search
Quote
| Back Zoom + Zoom - | ||||
|
TUNG YANG GUANG PHARMACEUTICAL (06887.HK) Showcases Three Innovative Drugs at 2026 AACR Annual Meeting
Recommend 4 Positive 2 Negative 0 |
||||
|
||||
|
TUNG YANG GUANG PHARMACEUTICAL (06887.HK) announced that at the 2026 American Association for Cancer Research (AACR) Annual Meeting held from April 17 to 22 in San Diego, California, the United States, the group presented the latest preclinical research results of three oncology pipeline candidates in the form of three poster presentations. The projects cover a CDH17/4-1BB bispecific antibody, an oral highly active Pan-RAS molecular glue inhibitor, and an oral small-molecule PD-L1 inhibitor. (de/d) Auto-translated by AI This article was automatically translated by AI, the original language version should be considered the authoritative version. AASTOCKS.com Limited does not guarantee its accuracy or completeness and accepts no liability for any damages or losses arising from the use of this translation. More Details
AASTOCKS Financial News |
||||
Copied to Clipboard
 |
||||
